This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan | MicrobiomeTrials
← Back to trials NCT06892249
Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan Completed NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-06-04Est. Completion: 2026-04-21
Enrollment target: 74 participantsLocations Kaosiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan Taipei TzuChi Hospital, New Taipei City, Taiwan Other microbiome trials you might be interested in Type 2 Diabetes Healthy (Controls)
The primary purpose of this study is to use multiomic data in combination with clinical assessments, electronic health r…
Orangeburg, United States Est. completion Aug 2029
CKD Metabolic Acidosis
The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-sev…
Chula Vista, United States Est. completion Jun 2027